NASDAQ:CRSP   CRISPR Therapeutics AG
Keeping an eye on CRSP as it heads into earnings. From the looks of it, this looks bottomed out. It is retesting its previous breakout, running into the 3d 100SMA and 21EMA.

I think there are better opportunities out there, but if it does retest this price area successfully it does have a chance to run some.

Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.